QY Research, Inc.

Global Metabolic Syndrome Market to Is Expected to Reach 36700 Million US$ by 2025

QY Research has offered a comprehensive assessment of the markets in the pharmaceutical & healthcare industry in its recently published research report. This evaluation is done on the basis of historical data, quantitative & qualitative insights and flexible projections about the size of the market. As per the requirement of pharmaceutical and healthcare industry, various techniques are used on an experimental basis to make this report an exclusive one. These techniques are patient-level data, insights on medical technology & devices and comprehensive data on a number of procedures.


City of Industry, CA -- (SBWIRE) -- 09/28/2018 -- This report focuses on the global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Syndrome development in United States, Europe and China.Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.

One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

The key players covered in this study

Novo Nordisk




Eli Lily


Actelion Pharmaceuticals


Aegerion Pharmaceuticals

Akros Pharma

Alnylam Pharmaceuticals



Amicus Therapeutics

Arbutus Biopharma

Market segment by Type, the product can be split into




Lysosomal storage diseases

Market segment by Application, split into




Market segment by Regions/Countries, this report covers

United States




Southeast Asia


Central & South America

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/645661/global-metabolic-syndrome-market

Market size split by Region
North America
Central & South America
Middle East & Africa

Buy Full Sterility Testing market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/d7ecb75ca5ab56457cf7eb6abd13ade0,0,1,Global%20Metabolic%20Syndrome%20Market%20Size%252C%20Status%20and%20Forecast%202018-2025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com